GlassScriptPhysician profile
Pushpal Rocky Banerjee
NPI 1669428371
$19,743.92
in general payments reported to CMS, 2019-2025
12 companies · $294 in 2025
The $294 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $9,311 · 2021: $6,839 · 2022: $1,824 · 2023: $685 · 2024: $198 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $7,659.35 | 2021-2023 | Ultomiris |
| Portola Pharmaceuticals, LLC | $6,785.86 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $1,534.05 | 2022-2023 | Andexxa |
| Zoll Medical Corporation | $933.18 | 2019-2025 | Defibrillator |
| Philips North America LLC | $187.82 | 2019-2022 | |
| Teleflex LLC | $182.82 | 2025 | Arrow, Quikclot |
| Stryker Corporation | $158.46 | 2019 | |
| Boston Scientific Corporation | $126.69 | 2020 | |
| Chiesi USA, INC. | $112.21 | 2020 | |
| Amgen INC. | $47.76 | 2022 | |
| Csl Behring | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pushpal Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.